Effect of oral administration with pravastatin and atorvastatin on airway hyperresponsiveness and allergic reactions in asthmatic mice

Annals of Allergy, Asthma and Immunology

Volumn 110, Issue 1, 2013, Pages 11-17

  Huang, Ching Feng ^a   Peng, Ho Jen ^b   Wu, Chia Chao ^a   Lo, Wen Tsung ^a   Shih, Yu Lueng ^a   Wu, Tzee Chung ^c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GAMMA INTERFERON; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; PRAVASTATIN;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; ASTHMA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ENZYME INHIBITION; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SPLEEN CELL; TH1 CELL; TH2 CELL; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CYTOKINES; FEMALE; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERSENSITIVITY; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; OVALBUMIN; PRAVASTATIN; PYRROLES; RATS, SPRAGUE-DAWLEY; TH1 CELLS;

EID: 84871018458     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.09.002     Document Type: Article

References (38)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
2. J. Shepherd, S.M. Cobbe, I. Ford West of Scotland Coronary Prevention Study Group Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
3. B. Kwak, F. Mulhaupt, S. Myit, and F. Mach Statins as a newly recognized type of immunomodulator Nat Med 6 2000 1399 1402
4. A.G. Tristano, and K. Fuller Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved Int Immunopharmacol 6 2006 1833 1846
5. J. Säfholm, C. Lövdahl, and L. Swedin Inflammation-induced airway smooth muscle responsiveness is strain dependent in mice Pulm Pharmacol Ther 24 2011 361 366
6. A.I. Blamoun, G.N. Batty, V.A. DeBari, A.O. Rashid, M. Sheikh, and M.A. Khan Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study Int J Clin Pract 62 2008 1373 1378
7. E. Hothersall, C. McSharry, and N.C. Thomson Potential therapeutic role for statins in respiratory disease Thorax 61 2006 729 734
8. Y. Chiba, S. Sato, and M. Misawa Inhibition of antigen-induced bronchial smooth muscle hyperresponsiveness by lovastatin in mice J Smooth Muscle Res 44 2008 123 128
9. L. Xu, X.W. Dong, and L.L. Shen Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma Int Immunopharmacol 12 2012 556 564
10. C.C. Huang, W.L. Chan, and Y.C. Chen Statin use in patients with asthma: a nationwide population-based study Eur J Clin Invest 41 2011 507 512
11. D. Menzies, A. Nair, K.T. Meldrum, D. Fleming, M. Barnes, and B.J. Lipworth Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma J Allergy Clin Immunol 119 2007 328 335
12. M. Ostroukhova, R.W. Kouides, and E. Friedman The effect of statin therapy on allergic patients with asthma Ann Allergy Asthma Immunol 103 2009 463 468
13. D.C. Cowan Simvastatin in the treatment of asthma: lack of steroid-sparing effect Throax 65 2010 891 896
14. Y. Chiba, J. Arima, H. Sakai, and M. Misawa Lovastatin inhibits bronchial hyperresponsiveness by reducing RhoA signaling in rat allergic asthma Am J Physiol Lung Cell Mol Physiol 294 2008 L705 L713
15. M.N. Abdel Rahman, and A.A. Abdelmotelb Study of atorvastatin in experimental allergic airway inflammation in mice Int Immunopharmacol 11 2011 1090 1094
16. A. McKay, B.P. Leung, I.B. McInnes, N.C. Thomson, and F.Y. Liew A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma J Immunol 172 2004 2903 2908
17. C.F. Huang, T.C. Wu, Y.H. Chu, K.S. Hwang, C.C. Wang, and H.J. Peng Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice Scand J Immunol 68 2008 502 510
18. C.F. Huang, C.C. Wang, T.C. Wu, C.H. Chu, and H.J. Peng Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG or cholera toxin on systemic Th2 immune responses and mucosal immunity in mice Ann Allergy Asthma Immunol 99 2007 443 452
19. G. Weitz-Schmidt, K. Welzenbach, and V. Brinkmann Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site Nat Med 7 2001 687 692
20. A.J. Robinson, D. Kashanin, F. O'Dowd, K. Fitzgerald, V. Williams, and G.M. Walsh Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions Clin Exp Allergy 39 2009 1866 1874
21. D.Y. Kim, S.Y. Ryu, J.E. Lim, Y.S. Lee, and J.Y. Ro Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model Eur J Pharmacol 557 2007 76 86
22. M. Imamura, K. Okunishi, and H. Ohtsu Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung Thorax 64 2009 44 49
23. Y. Chiba, S. Sato, and M. Misawa Upregulation of geranylgeranyltransferase I in bronchial smooth muscle of mouse experimental asthma: its inhibition by lovastatin J Smooth Muscle Res 46 2010 57 64
24. T. Ahmad, U. Mabalirajan, and A. Sharma Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma Am J Respir Cell Mol Biol 44 2011 531 539
25. S. Youssef, O. Stüve, and J.C. Patarroyo The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease Nature 420 2002 78 84
26. R. Hakamada-Taguchi, Y. Uehara, and K. Kuribayashi Inhibition of hydroxymethylglutaryl-coenzyme A reductase reduces Th1 development and promotes Th2 development Circ Res 93 2003 948 956
27. S.E. Dunn, S. Youssef, and M.J. Goldstein Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism J Exp Med 203 2006 401 412
28. E. Fujita, A. Shimizu, and Y. Masuda Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages Am J Pathol 177 2010 1143 1154
29. Y. Liu, H. Jiang, and W. Liu Effects of fluvastatin therapy on serum interleukin-18 and interleukin-10 levels in patients with acute coronary syndrome Acta Cardiol 65 2010 285 289
30. H.Y. Pan Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase Eur J Clin Pharmacol 40 1991 S15 S18
31. M. Gaga, E. Zervas, S. Grivas, M. Castro, and P. Chanez Evaluation and management of severe asthma Curr Med Chem 14 2007 1049 1059
32. M.C. Rizzo, and D. Solé Inhaled corticosteroids in the treatment of respiratory allergy: safety vs. efficacy J Pediatr (Rio J) 82 2006 S198 S205
33. D.W. Cockcroft Clinical concerns with inhaled beta2-agonists: adult asthma Clin Rev Allergy Immunol 31 2006 197 208
34. A. Bharadwaj, and D.K. Agrawal Immunomodulation in asthma: a distant dream or a close reality? Int Immunopharmacol 4 2004 495 511
35. F. Gao, L. Linhartova, A.M. Johnston, and D.R. Thickett Statins and sepsis Br J Anaesth 100 2008 288 298
36. S.F. Suglia, E.C. Chambers, A. Rosario, and C.S. Duarte Asthma and obesity in three-year-old urban children: role of sex and home environment J Pediatr 159 2011 14 20
37. Q. Zhang, K. Lai, J. Xie, G. Chen, and N. Zhong Does unrestrained single-chamber plethysmography provide a valid assessment of airway responsiveness in allergic BALB/c mice? Respir Res 10 2009 61
38. D.G. Frazer, J.S. Reynolds, and M.C. Jackson Determining when enhanced pause (Penh) is sensitive to changes in specific airway resistance J Toxicol Environ Health A 74 2011 287 295